Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-004909

CVP, TAVR sold 2,038 shares at an average $83.49 ($170,160)

  • CVP, TAVR acquired 2,038 shares (option exercise)
  • CVP, TAVR gave up 252 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, TAVR

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-01 Exercise or conversion : show line 1 in the form 10b5-1 +1,019 $59.26 $60,383 34,952.91 D
2026-05-01 Sale : show line 2 in the form 10b5-1 −19 $83.99 $1,596 34,933.91 D
2026-05-01 Sale : show line 3 in the form 10b5-1 −1,000 $82.99 $82,989 33,933.91 D
2026-05-03 Shares withheld for taxes : show line 4 in the form 10b5-1 −252 $83.98 $21,163 33,681.91 D
2026-05-04 Exercise or conversion : show line 5 in the form 10b5-1 +1,019 $59.26 $60,383 34,700.91 D
2026-05-04 Sale : show line 6 in the form 10b5-1 −1,019 $83.98 $85,576 33,681.91 D
Open-market sales · 2,038 sh · avg $83.49 · $170,160

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-05-01 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) −1,019 1,019 D
2026-05-04 Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (Right to Acquire) −1,019 0 D
Loading xslF345X06/doc4.xml…